Full article view2018-07-17T08:45:50+00:00
Back to News & Insights »

Press Release: Precision for Value Relocates NYC Office to Accommodate Rapid Growth and Expanding Talent

New Office Space at One Grand Central Place Bolsters Square Feet to Nearly 18,000 

December 8, 2016 – New York, NY – Precision for Value, the market leader in supporting global pharmaceutical and life sciences companies in achieving commercial excellence, announced the move of its New York City office into a larger location in midtown Manhattan to accommodate rapid growth and an expanding workforce. The office will now be located in One Grand Central Place at 60 East 42nd Street. The nearly 18,000 square foot space will be home to over 80 employees.

“Overall, we’ve seen remarkable growth this year, both in our talent pool, which now includes over 380 employees across 12 locations in North America and Europe, and in revenue, which experienced another year of double digit growth, taking us past the $100 million threshold.” said Dan Renick, president, Precision for Value. “We are excited by the prospect of further growth of the company in the coming year as we continue to meet the needs of our clients, which currently include over 80 biopharmaceutical and device manufactures.”

In addition to the New York expansion, this year Precision for Value has increased its workforce in Boston, Chicago, Los Angeles and London. Most recently, new Precision employees have been added to the Specialty Solutions, Formulary Access Solutions, and Quality and Population Health Solutions business units of the Precision Payer Strategy Team.

Many of these new hires have been in response to the pharmaceutical industry’s urgent need to leverage real-world market insights in the face of growing government and payer scrutiny over drug pricing and access.

“Precision for Value has strategically assembled an industry-leading team of former payer decision makers with direct understanding of the evolving drug marketplace and strong ties to their current counterparts,” said Kelly Wilder, EVP, managing partner and leader of the Precision Payer Strategy Team. “By understanding how payers measure the value of treatments, Precision for Value has created new levels of market access for innovative medications.”

About Precision for Value

Precision for Value supports commercial excellence for global pharmaceutical and life sciences clients through the demonstration and communication of product value and outcomes. The Precision for Value teams provide clients with services grounded in decades of industry knowledge, demonstrated analytics proficiency, and marketing and communications prowess — making Precision for Value the preferred strategic partner in the industry. Visit www.precisionforvalue.com for more information.

# # #

Media Contact
Louis Landon, Precision for Value Media Relations
310-984-7707
louis.landon@precisionhealtheconomics.com

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.

OK